Aether Industries Limited

BSE:543534 Stock Report

Market Cap: ₹109.9b

Aether Industries Valuation

Is 543534 undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

1/6

Valuation Score 1/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 543534 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: Insufficient data to calculate 543534's fair value for valuation analysis.

Significantly Below Fair Value: Insufficient data to calculate 543534's fair value for valuation analysis.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 543534?

Key metric: As 543534 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 543534. This is calculated by dividing 543534's market cap by their current earnings.
What is 543534's PE Ratio?
PE Ratio103x
Earnings₹1.07b
Market Cap₹109.93b

Price to Earnings Ratio vs Peers

How does 543534's PE Ratio compare to its peers?

The above table shows the PE ratio for 543534 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average38.5x
BLUEJET Blue Jet Healthcare
55.5x20.2%₹130.2b
500126 Procter & Gamble Health
41x11.3%₹89.4b
500674 Sanofi India
24x-2.6%₹127.3b
ALIVUS Alivus Life Sciences
33.3x27.4%₹147.1b
543534 Aether Industries
103x42.2%₹109.9b

Price-To-Earnings vs Peers: 543534 is expensive based on its Price-To-Earnings Ratio (103x) compared to the peer average (38.5x).

Price to Earnings Ratio vs Industry

How does 543534's PE Ratio compare vs other companies in the IN Pharmaceuticals Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
INDSWFTLAB Ind-Swift Laboratories
1.8xn/aUS$76.59m
524652 Ind-Swift
1.9xn/aUS$11.94m
No more companies available in this PE range
543534 103.0xIndustry Avg. 31.2xNo. of Companies20PE020406080100+
2 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: 543534 is expensive based on its Price-To-Earnings Ratio (103x) compared to the Indian Pharmaceuticals industry average (31.2x).

Price to Earnings Ratio vs Fair Ratio

What is 543534's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

543534 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio103x
Fair PE Ratio52.8x

Price-To-Earnings vs Fair Ratio: 543534 is expensive based on its Price-To-Earnings Ratio (103x) compared to the estimated Fair Price-To-Earnings Ratio (52.8x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 543534 forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current₹826.70
₹1,057.20
+27.9%
8.6%₹1,142.00₹890.00n/a5
Jan ’26₹883.05
₹1,043.60
+18.2%
11.6%₹1,140.00₹810.00n/a5
Dec ’25₹823.05
₹1,097.00
+33.3%
2.9%₹1,135.00₹1,060.00n/a4
Nov ’25₹852.45
₹1,097.00
+28.7%
2.9%₹1,135.00₹1,060.00n/a4
Oct ’25₹949.15
₹1,047.50
+10.4%
4.6%₹1,117.00₹983.00n/a4
Sep ’25₹889.75
₹1,047.50
+17.7%
4.6%₹1,117.00₹983.00n/a4
Aug ’25₹893.85
₹1,047.00
+17.1%
4.6%₹1,115.00₹983.00n/a4
Jul ’25₹925.05
₹1,046.50
+13.1%
6.7%₹1,153.00₹968.00n/a4
Jun ’25₹804.10
₹1,046.50
+30.1%
6.7%₹1,153.00₹968.00n/a4
May ’25₹833.20
₹1,084.25
+30.1%
4.2%₹1,153.00₹1,029.00n/a4
Apr ’25₹801.70
₹1,083.25
+35.1%
3.7%₹1,124.00₹1,029.00n/a4
Mar ’25₹868.65
₹1,083.25
+24.7%
3.7%₹1,124.00₹1,029.00n/a4
Feb ’25₹864.70
₹1,068.00
+23.5%
3.7%₹1,120.00₹1,024.00₹826.703
Jan ’25₹882.95
₹1,071.33
+21.3%
4.1%₹1,130.00₹1,024.00₹883.053
Dec ’24₹795.15
₹1,071.33
+34.7%
4.1%₹1,130.00₹1,024.00₹823.053
Nov ’24₹870.20
₹1,095.00
+25.8%
3.2%₹1,130.00₹1,060.00₹852.452
Oct ’24₹967.90
₹1,085.00
+12.1%
2.3%₹1,110.00₹1,060.00₹949.152
Sep ’24₹990.65
₹1,085.00
+9.5%
2.3%₹1,110.00₹1,060.00₹889.752
Aug ’24₹1,088.50
₹1,085.00
-0.3%
2.3%₹1,110.00₹1,060.00₹893.852
Jul ’24₹1,067.65
₹1,070.00
+0.2%
0.9%₹1,080.00₹1,060.00₹925.052
Feb ’24₹880.10
₹892.50
+1.4%
18.8%₹1,060.00₹725.00₹864.702
Analyst Price Target
Consensus Narrative from 5 Analysts
₹1.05k
Fair Value
21.6% undervalued intrinsic discount
5
Number of Analysts

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/01/31 10:56
End of Day Share Price 2025/01/31 00:00
Earnings2024/12/31
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Aether Industries Limited is covered by 7 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
null nullAsian Markets Securities Private Limited
Nitin AgarwalDAM Capital Advisors
Nilesh GhugeHDFC Securities Limited